Table 2 RDA sample adequacy and morphologic diagnosis of FNA samples acquired during CHOP chemotherapy administration
From: RNA disruption indicates CHOP therapy efficacy in canine lymphoma
Time Sample Acquired | Number of RDA Adequate Samples | Number of RDA Inadequate Samples | Total Samples for RDA | % Inadequate Samples | Total Samples for Cytology | Number of “No Diagnosis”Samples | % “No Diagnosis”Samples |
|---|---|---|---|---|---|---|---|
0 | 39 | 2 | 41 | 5 | 40 | 6 | 15 |
2–3 weeks | 25 | 7 | 32 | 22 | 30 | 11 | 37 |
4–6 weeks | 16 | 16 | 32 | 50 | 32 | 16 | 50 |
7+ weeks | 24 | 15 | 39 | 38 | 36 | 16 | 44 |